Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement

CONTEXT: Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect on pulmonary artery pressure (PAP) and right ve...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Card Anaesth
Prif Awduron: Kundra, Tanveer Singh, Nagaraja, P S, Bharathi, K S, Kaur, Parminder, Manjunatha, N
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Medknow Publications & Media Pvt Ltd 2018
Pynciau:
Original Article: Janak Mehta Award
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6078018/
https://ncbi.nlm.nih.gov/pubmed/30052230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aca.ACA_19_18
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg